Fig. 3

Diagnostic power of plasma exosomal miR-223 for EOC. a Correlation analysis of plasma exosomal miR-223 with CA125 in EOC group. b ROC curve analysis for exosomal miR-223, CA125, and combined indicators for EOC patients relative to non-EOC subjects. c ROC curve analysis for exosomal miR-223, CA125, and combined indicators for EOC patients relative to healthy subjects. d ROC curve analysis for exosomal miR-223, CA125, and combined indicators for metastatic EOC patients relative to non-metastatic EOC patients. e ROC curve analysis for exosomal miR-223, CA125, and their combination for discriminating EOC patients at early-stage from healthy subjects